Details for New Drug Application (NDA): 074099
✉ Email this page to a colleague
NDA 074099 describes ATENOLOL, which is a drug marketed by Able, Apothecon, Aurobindo Pharma, Chartwell Rx, Hlthcare, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, SCS, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Twi Pharms, Unichem, Unique, Watson Labs, Watson Labs Teva, Zydus Pharms Usa, Aurobindo Pharma Usa, Novitium Pharma, and Zydus Pharms, and is included in thirty-nine NDAs. It is available from thirty-three suppliers. Additional details are available on the ATENOLOL profile page.
The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
Summary for 074099
| Tradename: | ATENOLOL |
| Applicant: | Strides Pharma |
| Ingredient: | atenolol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 074099
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Apr 28, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
